CG
ACHV icon

Cutler Group’s Achieve Life Sciences ACHV Stock Holding History

Cutler Group’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-479
Closed -$2K – 3536
2023
Q3 		$2K Hold
479
– – ﹤0.01% 3207
2023
Q2 		$2K Sell
479
-621
-56% -$4.36K ﹤0.01% 2948
2023
Q1 		$7K Buy
+1,100
New +$5.23K ﹤0.01% 2511
2017
Q2 		– Sell
-5
Closed -$4K – 6265
2017
Q1 		$4K Hold
5
– – ﹤0.01% 4842
2016
Q4 		$5K Hold
5
– – ﹤0.01% 4851
2016
Q3 		$5K Hold
5
– – ﹤0.01% 4895
2016
Q2 		$11K Sell
5
-3
-38% -$6.26K ﹤0.01% 3995
2016
Q1 		$12K Sell
8
-1
-11% -$1.63K ﹤0.01% 3819
2015
Q4 		$25K Buy
+9
New +$38K ﹤0.01% 3169

Other funds holding ACHV

SC
Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return

Cutler Group's ACHV Position: Q4 2023 in Review

Cutler Group sold out of Achieve Life Sciences (ACHV) in Q4 2023, closing a stake of 479 shares — an estimated $2K sold.

Cutler Group first reported a position in ACHV in Q4 2015 and held it in 9 quarters. The position peaked at $25K in Q4 2015. 30 funds tracked by Wall St. Rank hold ACHV as of Q4 2023.

  • Cutler Group reported no remaining Achieve Life Sciences position as of Q4 2023 after selling out during the quarter.
  • Cutler Group sold 479 Achieve Life Sciences shares in Q4 2023, an estimated $2K.
  • Cutler Group first reported a position in Achieve Life Sciences in Q4 2015 and held it in 9 quarters.
  • Cutler Group's Achieve Life Sciences position peaked at $25K in Q4 2015.
  • 30 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q4 2023.

Based on Cutler Group's 13F filing for Q4 2023, filed 18 Jan 2024.